What Are Brain Tumors?

Brain tumors are abnormal masses of cells that grow within the brain or the tissues and structures immediately surrounding it, including the meninges, cranial nerves, and pituitary gland. They span a wide range of behavior, from slow-growing benign lesions that may never require treatment to rapidly infiltrating malignancies. Because the skull is a fixed volume, even a histologically benign tumor can be dangerous once it displaces tissue, obstructs cerebrospinal fluid flow, or raises intracranial pressure. That mechanical constraint separates neuro-oncology from cancer medicine elsewhere in the body and explains why location often matters as much as cell type.

The category divides first by origin. Primary brain tumors begin in central nervous system tissue and include gliomas, meningiomas, pituitary adenomas, schwannomas, medulloblastomas, and primary central nervous system lymphoma. Secondary or metastatic tumors seed from cancers arising elsewhere and outnumber primary tumors in adults. Meningiomas are the most frequently diagnosed primary intracranial tumor overall, while in children the mix shifts toward posterior fossa lesions such as medulloblastoma and pilocytic astrocytoma.

Classification and Grading

Tumors are named for the cell type they resemble and graded on a World Health Organization scale from 1 to 4 that reflects how aggressively they are expected to behave. Grades 1 and 2 are described as low grade, grades 3 and 4 as high grade. The 2021 edition of the classification restructured many entities around molecular findings rather than appearance alone, so that markers such as IDH mutation, 1p/19q codeletion, and H3 alterations now define diagnoses that were previously distinguished under the microscope. Rare mixed entities complicate the picture further, including gliosarcoma, which combines glial and sarcomatous components. Pediatric classification diverges substantially from adult practice, and the National Cancer Institute's treatment summary for childhood astrocytomas and other gliomas reflects that separation.

Imaging and Diagnosis

Presentation is usually neurological rather than systemic: headache with a characteristic pattern, seizures, focal weakness, visual field loss, or cognitive change. Magnetic resonance imaging with and without gadolinium contrast is the primary diagnostic study, supplemented by computed tomography when calcification, bone involvement, or acute hemorrhage is in question. Advanced sequences extend what imaging can resolve, including diffusion tensor imaging for white matter tract mapping before surgery, perfusion imaging for vascularity, and spectroscopy for metabolite profiles. A survey of these methods appears in a review of imaging in neuro-oncology. Imaging alone rarely settles the diagnosis, so tissue from stereotactic biopsy or resection is examined by a neuropathologist, and standardized response criteria are used to judge whether a lesion is progressing.

Treatment and Management

Management depends on grade, location, patient age, and functional status. Some low-grade or incidentally discovered lesions are simply observed with serial imaging. Where intervention is indicated, surgical resection serves both to obtain tissue and to relieve mass effect, guided by neuronavigation, intraoperative imaging, and functional mapping of speech and motor cortex. Radiotherapy follows for most high-grade tumors and for some incompletely resected benign ones, delivered as fractionated external beam treatment or as stereotactic radiosurgery for small, well-defined targets such as metastases and vestibular schwannomas. Systemic therapy varies widely by tumor type, and supportive measures including corticosteroids, antiepileptic drugs, and cerebrospinal fluid shunting address symptoms directly. Current treatment options across tumor types are catalogued by the National Cancer Institute.

Applications

Brain tumor research and care draw on a range of technical fields, including:

• Magnetic resonance imaging hardware and pulse sequence development
• Automated tumor segmentation and machine learning for image analysis
• Image-guided surgery, neuronavigation, and surgical robotics
• Radiation treatment planning and stereotactic radiosurgery
• Molecular diagnostics and high-throughput DNA sequencing
• Neuroprosthetic and rehabilitation engineering for post-treatment deficits